Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of April 2020. The report serves to notify shareholders of a Special Meeting of Shareholders scheduled for April 21, 2020, at the company's offices in Petach-Tikva, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus a prior comparable period are reported in this filing. The primary event is the announcement of the upcoming Special Meeting of Shareholders.
Guidance, Outlook, and Management Commentary
Management has announced the Special Meeting to vote on a proposal described in the attached Notice and Proxy Statement (Exhibit 99.1). The filing includes forms for voting by proxy for both ordinary share holders (Exhibit 99.2) and American Depositary Share holders (Exhibit 99.3). No specific financial guidance, risk factors, or contingencies are detailed in the body of this report.
Key Facts for Investor Verification
- Special Meeting of Shareholders date: April 21, 2020.
- Meeting time: 4:00 P.M. Israel time.
- Meeting location: Company offices in Petach-Tikva, Israel.
- Investors must review Exhibit 99.1 to understand the specific proposal to be voted upon.
- Voting instructions are provided via Exhibit 99.2 (ordinary shares) and Exhibit 99.3 (ADS holders).